Platelet Rich Plasma Market (Type: Pure PRP, Leukocyte-rich PRP, and Pure PRF; Origin: Autologous, Allogenic, and Homologus; and Application: Orthopedic Surgery, Cosmetic Surgery, General Surgery, Neurosurgery, and Others) - Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2021-2027
The global Platelet Rich Plasma market gathered revenue around USD 430 Million in 2020 and market is set to grow USD 1.0 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 11.0% during the prediction period 2021 to 2027.
The market Plasma is found in the blood, which contains factors such as protein that support cell growth. Researchers and practitioners produce platelet rich plasma (PRP) by isolating plasma from blood and concentrating it. PRP is injected in the damaged tissues, which stimulates faster growth of healthy cells, resulting in rapid healing of injuries and diseases. The tissue growth factors are more concentrated in the platelet rich plasma injections, which support faster healing of body tissues.
Sport injuries have increased in the last two decades. Shoulder, elbow, and knee are the most common sports injuries among baseball and softball players. According to the Johns Hopkins Medicine’s report, 3.5 million sport injuries are reported among young sports participants each year. Platelet rich plasma is used to treat a range of sports and acute injuries, which result in joint, tendon, and ligament pain. Researches and clinical practice have also indicated faster recovery from injuries and pain with the help of PRP treatment, which fueled the growth of the global market.
The rise in hair loss treatment is also a major driver of the global market. Hair loss has become a major concern among the people globally. It is not an uncommon scenario among people to lose hair prematurely instead of losing them due to the natural aging process. The platelet rich plasma treatment is a quite effective and safe method for treating hair loss. The PRP treatment is very helpful in hair loss treatment due to its unique property of promoting tissue repair, collagen growth, and healthy cell production.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Platelet Rich Plasma market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Platelet Rich Plasma market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
|Market Size||USD 1.0 Billion by 2027|
|Growth Rate||CAR 11.0% From 2021 to 2027|
|Forecast Period||2021 to 2027|
|Largest Market||North America|
|Fastest Growing Market||Asia Pacific|
|Segments Covered||Type, Origin, Application and Region|
|Report coverage||Growth Factors, Revenue Status, Competitive Landscape, and Future Trends|
|Companies Mentioned||Zimmer Biomet, AdiStem Ltd., ISTO Biologics, ThermoGenesis Holdings, Inc., Stryker Corporation, Exactech, Inc., EmCyte Corporation, Regen Lab, Arthrex, Inc., TERUMO BCT, INC. (Terumo Corporation), DePuy Synthes Companies (Johnson & Johnson),|
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Platelet Rich Plasma market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
North America dominated the market and accounted for the largest revenue share of 46.0% in 2020. This can be attributed to increased awareness about platelet rich plasma treatments, technological advancements, and the rising number of cosmetics surgeries in the region. Active involvement of academic and research institutes, such as Yale School of Medicine and Springfield College of Health Care, Management and Technology, for evaluating the application of platelet-rich plasma therapies further accelerates market growth in the region.
In addition, the presence of supportive regulatory authorities is further driving the market growth in North America. The U.S.FDA’s Center for Biologics Evaluation and Research is the regulatory body responsible for platelet rich plasma products. The CBER grants 510(k) application approval for marketing of platelet rich plasma preparation systems in the U.S. Thus, a strong commercial and research base for platelet rich plasma therapies is contributing to the growth of the market in the region.
Asia Pacific is anticipated to witness the highest CAGR of 13.9% from 2021 to 2027. The rising number of cosmetic surgeries to improve facial features in countries such as Korea, India, and Thailand is anticipated to boost the market growth in the region. In addition, the growing medical tourism industry in the region is expected to boost the adoption of the market. Furthermore, active involvement of academic and research institutes, such as the University of Tsukuba and Guangzhou University of Chinese Medicine, for evaluating the application of platelet rich plasma therapies.
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
- Company Overview
- Company Market Share/Positioning Analysis
- Product Offerings
- Financial Performance
- Recent Initiatives
- Key Strategies Adopted by Players
- Vendor Landscape
- List of Suppliers
- List of Buyers
Some of the prominent players in the Platelet Rich Plasma Market include: Zimmer Biomet, AdiStem Ltd., ISTO Biologics, ThermoGenesis Holdings, Inc., Stryker Corporation, Exactech, Inc., EmCyte Corporation, Regen Lab, Arthrex, Inc., TERUMO BCT, INC. (Terumo Corporation), DePuy Synthes Companies (Johnson & Johnson), Celling Biosciences, Inc., and Juventix Regenerative Medical, LLC.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
Platelet Rich Plasma Market, by Type
- Leukocyte-rich PRP
Platelet Rich Plasma Market, by Origin
Platelet Rich Plasma Market, by Application
- Orthopedic Surgery
- Cosmetic Surgery
- General Surgery
- United Kingdom
- Rest of Europe
- Southeast Asia
- Rest of Asia Pacific
- Rest of Latin America
Middle East & Africa (MEA)
- North Africa
- South Africa
- Rest of Middle East & Africa
Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Platelet Rich Plasma market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the Platelet Rich Plasma market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Platelet Rich Plasma markets more accurate and reliable.
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire based research etc.
- In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
Industry participants involved in this research study include:
- CEOs, VPs, market intelligence managers
- Procuring and national sales managers technical personnel, distributors and resellers
- Research analysts and key opinion leaders from various domains
Key Points Covered in Platelet Rich Plasma market Study:
- Growth of Platelet Rich Plasma in 2021
- Market Estimates and Forecasts (2017-2027)
- Brand Share and Market Share Analysis
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Recommendation on Key Winning Strategies
- COVID-19 Impact on Demand for Platelet Rich Plasma and How to Navigate
- Key Product Innovations and Regulatory Climate
- Platelet Rich Plasma Consumption Analysis
- Platelet Rich Plasma Production Analysis
- Platelet Rich Plasma and Management